ReviewInternational journal of molecular sciences2026
Extracellular Vesicles for Corneal Endothelial Repair.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The corneal endothelium is essential for maintaining corneal transparency and visual function through regulation of stromal hydration. However, human corneal endothelial cells have limited regenerative capacity in vivo, and their loss due to aging, trauma, surgery, or diseases such as Fuchs endothelial corneal dystrophy can lead to corneal oedema and visual impairment. Although corneal transplantation remains the primary treatment for endothelial dysfunction or loss, donor tissue shortages and postoperative complications have driven the search for alternative therapies. Extracellular vesicles (EVs) have emerged as promising cell-free therapeutic agents that mediate intercellular communication through the transfer of bioactive molecules. Recent studies have investigated two distinct EV sources in corneal endothelial biology: mesenchymal-stem-cell-derived EVs, which have demonstrated cytoprotective and regenerative effects, and corneal endothelial cell-derived EVs, which appear to modulate endothelial homeostasis and, depending on their cargo, may either limit proliferation or exert protective effects. This review summarizes current evidence on EV biology, their distinct cellular sources, and their potential roles in corneal endothelial repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.